Discover five leading male transformation experts in aesthetic medicine, renowned for natural-looking results, facial masculinisation and innovative treatments.

The UK sun care market continues to grow rapidly as consumers increasingly prioritise SPF and skin protection, new research shows.

The MHRA has approved the UK’s first GLP-1 weight loss tablet, semaglutide (Wegovy), for eligible adults with obesity or overweight and related health conditions. The once-daily oral treatment offers an alternative to injections, with NHS availability subject to NICE approval.

Aesthetic Medicine spoke to experts Dr Veerle Rotsaert and Dr Natasha Berridge to discover the role injectables can play in supporting transgender and gender-diverse patients.